Effects of a dosing solution on the nasal absorption of non- glycosylated recombinant human granulocyte colony-stimulating factor in rats

Biological and Pharmaceutical Bulletin

Volumn 19, Issue 11, 1996, Pages 1490-1493

  Nomura, Hideaki ^a   Akamisaka, Satoshi ^a   Maruyama, Kazutoshi ^a  

^a KIRIN BREWERY CO LTD   (Japan)

Author keywords

enhancer; granulocyte colony stimulating factor; nasal absorption; osmotic pressure; pH

Indexed keywords

ASCORBIC ACID; BETA CYCLODEXTRIN; CHOLIC ACID; DIMETHYL BETA CYCLODEXTRIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TARTARIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG POTENTIATION; ESCHERICHIA COLI; GLYCOSYLATION; IMMUNOTHERAPY; INTRANASAL DRUG ADMINISTRATION; MALE; NONHUMAN; NOSE; OSMOTIC PRESSURE; PH MEASUREMENT; RAT;

EID: 0029846793     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.19.1490     Document Type: Article

References (17)

1. Takada K., Tohyama Y., Oohashi M., Yoshikawa H., Muranishi S., Shimosaka A., Kaneko T., Chem. Pharm. Bull., 31, 838-839 (1989).
2. Takada K., Nakahigashi Y., Tanaka T., Kishimoto S., Ushirogawa Y., Takaya T., Int. J. Pharm., 101, 89-96 (1994).
3. Ushirogawa Y., Nakahigashi Y., Kiriyama A., Takada K., Int. J. Pharm., 81, 133-141 (1992).
4. Niven R. W., Lott F. D., Cribbs J. M., Pharm. Res., 10, 1604-1610 (1993).
5. Niven R. W., Lott F. D., Ip A. Y., Cribbs J. M., Pharm. Res., 11, 1101-1109 (1994).
6. Chien Y. W., Su K. S. E., Chang S. F., "Nasal Systemic Drug Delivery," Dekker, New York., 1989, pp. 1-26.
7. Machida M., Sano K., Arakawa M., Hayashi M., Awazu S., Pharm. Res., 10, 1372-1377 (1993).
8. Machida M., Sano K., Arakawa M., Hayashi M., Awazu S., Biol. Pharm. Bull., 17, 1375-1378 (1994).
9. Watanabe Y., Matsumoto Y., Yamaguchi M., Kikuchi R., Takayama K., Nomura H., Maruyama K., Matsumoto M., Biol. Pharm. Bull., 16, 93-95 (1993).
10. Watanabe Y., Matsumoto Y., Kikuchi R., Kiriyama M., Ito R., Matsumoto M., Nomura H., Maruyama K., Int. J. Pharm., 110, 93-97 (1994).
11. Souza L.M., Boon T. C., Gabrilove J., Lai P. H., Zsebo K. M., Murdock D. C., Chazin V. R., Bruszewski J., Lu H., Chen K. K., Barendt J., Platzer E., Moore M. A. S., Mertelsmann R., Weite K., Science, 232, 61-65 (1986).
12. Hirai S., Yashiki T., Matsuzawa T., Mima H., Int. J. Pharm., 7, 317-325 (1981).
13. Tanaka H., Tokiwa T., J. Pharmacol. Exp. Ther., 255, 734-729 (1990).
14. Irie T., Wakamatsu K., Arima H., Aritomi H., Uekama K., Int. J. Pharm., 84, 129-139 (1992).
15. Maitani Y., Igawa T., Machida Y., Nagai T., Drug Design and Delivery, 1, 65-70 (1986).
16. Hirai S., Yashiki T., Mima H., Int. J. Pharm., 9, 173-184 (1981).
17. Nishimura K., Nozaki Y., Yoshimi A., Nakamura S., Kitagawa M., Kakeyama N., Kitao K., Chem. Pharm. Bull., 33, 282-291 (1985).